Download a fully functional 30-day trial version of either StatXact® - the most widely used exact statistics software or LogXact® for small-sample logistic regression.
Cytel's validated clinical trial software and services are proven to help better plan and implement trials that not only meet the study objectives, but also improve the sponsor's overall clinical development strategy.
Whether adaptive or traditional, frequentist or Bayesian, phased or seamless, sponsor companies worldwide rely on Cytel's statistical expertise and clinical know-how to determine and execute approaches with the best chance of success.
By reducing the number of patients and amount of time typically needed to conduct a clinical study, adaptive trials can save money while helping increase your pipeline efficiency. They provide an essential edge in moving your products through the clinical development process.
Pioneers of the statistics behind adaptive trials, Cytel's experience in adaptive designs, simulation technologies and clinical supply logistics make trial innovations practical.
That's why pharmaceutical, biotechnology and device companies around the world turn to Cytel's adaptive trial expertise.
June webinar of Cytel Co-Founder and President, Cyrus Mehta demonstrating the new EastAdapt capabilities.
Webinar info and registration link
Cytel Assoc. Director of Biostatistics, Yannis Jemiai presents Adaptive Designs for Confirmatory Stage Oncology Trials
Location details and registration
Adaptive trials leader and CDRH regulators join to create Bayesian trial design and analysis software standard
Read more
Cytel’s Vice President of Adaptive Trials joins fellow industry colleagues and FDA spokesperson on the 5th anniversary of the Critical Path Initiative
Read more